Are consumers ready to take part in the Pharmacovigilance System?—a Portuguese preliminary study concerning ADR reporting | Zendy

Cristiano Matos | Zendy; Florence van Hunsel | Zendy; João Joaquim | Zendy

Open Access

Are consumers ready to take part in the Pharmacovigilance System?—a Portuguese preliminary study concerning ADR reporting

Author(s) -

Cristiano Matos,

Florence van Hunsel,

João Joaquim

Publication year - 2015

Publication title -

european journal of clinical pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.845

H-Index - 108

eISSN - 1432-1041

pISSN - 0031-6970

DOI - 10.1007/s00228-015-1867-2

Subject(s) - pharmacovigilance , descriptive statistics , medicine , family medicine , likert scale , pharmacy , portuguese , health care , legislation , psychology , adverse effect , pharmacology , political science , developmental psychology , linguistics , statistics , philosophy , mathematics , law

New pharmacovigilance legislation allows consumers to report adverse drug reactions (ADRs) directly to competent authorities in all European Union countries. Consumer reporting is available in Portugal since July 2012. In 2013, the National Pharmacovigilance System (SNF) had received 3461 spontaneous ADR reports, of which only 1.4% (n = 50) were from consumers. Consumer reporting could be one opportunity to reduce underreporting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research